A novel synthesis of thiazolidine-2-thione and thiazolidin-2-one derivatives is described with the iodo-cyclothiocarbamation reaction as the key step for the heterocyclic ring formation. This new method has been applied to the synthesis of thiazolidinones as bioisosteric analogs of Linezolid 2. Antimicrobial properties of two new thiazole derivatives are reported.
Introduction
Oxazolidinones have attracted attention as a new class of orally active synthetic antibiotics with a unique mechanism of bacterial protein synthesis inhibition. [1] [2] [3] [4] One of the early oxazolidinones studied in detail was DuP-721 (1) 5 ( Figure 1 ) exhibiting a broad spectrum of antibacterial activity including activity against drug-resistant Gram positive bacteria as well as several anaerobes and Mycobacterium tuberculosis. However, further development of DuP-721 (1) was discontinued because of safety concerns in animal models. Continued efforts led to the identification of Linezolid (2) 4, 6 ( Figure 1 ) with excellent activity against ever increasing Methicillin Resistant Staphylococcus aureus (MRSA) and with a better safety profile; Linezolid was approved for clinical use in 2001. However, adverse effects are its potential for inhibition of monoamine oxidase and myelosuppression. Practically all oxazolidinones studied so far have shown the potential for myelosuppression. 6b Therefore, it has been an objective to identify a molecule with not only a wider spectrum of antibacterial activities but also providing a better safety profile. So far, most synthetic efforts have been directed at modifying substituents in the aromatic ring of 1 and 2. 7 Recently, changes at the 5-methylene group have also been reported. 8 However, these efforts have not led to a 'better Linezolid'.
We attempted subtle and bioisosteric changes in the pharmacophore oxazolidinone in order to study the impact of these changes on desirable antibacterial activity and also adverse toxicities. Therefore, we considered the modification of the oxazolidinone ring by replacing the ring oxygen by the bulkier sulfur atom leading to thiazolidines; 9 thiazolidinethione 3 and thiazolidinone 4 ( Figure 2 ) were chosen as targets. Seneci et al. 10 have reported the synthesis of ring-modified oxazolidinone analogs of 1 by introducing as nitrogen, sulfur and phosphorus atoms. Introduction of sulfur was expected to bring in a bulky polarisable atom, thus altering geometry, polarisability, stability, lipophilicity and steric and electronic characteristics of the molecule. It was anticipated that the thiazolidine ring improves the activity of the lead molecules. However, the strategy for the preparation of the corresponding thiazolidine-2-ones, based on thiirane ring opening by a carbamate, proved unsuccessful. 10 Seneci et al. succeeded in synthesizing oxazolidine-2-thione 5 by the hydrolysis of the oxazolidinone ring of 1 followed by ring closure with thiophosgene (Scheme 1).
Compound 5 exhibited reduced antibacterial activity (MIC against MRSA was 64-128 µg/mL). A general strategy for the synthesis of thiazolidine rings was required that could lead to this new class of compounds. There is a report 11 on the iodo-cyclisation of N-allyl-and S-allylthioureas for the synthesis of dihydrothiazoles (Scheme 2, Eq. 1 and 2); the synthesis of achiral oxazolidinones utilizes an iodo-cyclocarbamation reaction. 12 By the latter reaction an N-allylcarbamate 6 is cyclized using iodine through the intermediacy of an iodonium species 7 leading to oxazolidinones 8 (Scheme 2, Eq. 3). Our strategy to synthesize the thiazolidinones was to employ a hitherto unknown iodo-cyclothiocarbamation reaction as the key step involving a dithiocarbamate in place of a carbamate for the iodo-cyclisation reaction. The use of this method would lead to the synthesis of racemic thiazolidinones. Only the S enantiomer of the antibacterial oxazolidin-2-ones is active, the R enantiomer is completely inactive, and we expected that the biological activity of the thiazolidinone racemate would be reduced by 50%. 
Results and Discussion

Synthesis
Retrosynthetic analysis (Scheme 3) identifies 2-iodomethylthiazolidine-2-thione as key intermediate, which can conceivably be obtained by an iodo-cyclisation reaction of an N-allyldithiocarbamate. This dithiocarbamate could be synthesized by N-allylation of the corresponding thiourethane that is available by the S-alkylation of the triethylammonium dithiocarbamate derived from a primary amine. The thiazolidine-2-thione could then be converted into the desired 5-(acetylaminomethyl)thiazolidine-2-thiones and thiazolidin-2-ones. Condensation of aniline (9a) with carbon disulfide in the presence of triethylamine gave the corresponding dithiocarbamate salt 10a; subsequent alkylation with benzyl bromide furnished the corresponding S-benzyl derivative 11a (Scheme 3); N-allylation of 11a using sodium hydride and allyl bromide in the presence of tetrabutylammonium iodide gave the N-allyl derivative 12a. The key reaction of iodo-cyclothiocarbamation went smoothly and was carried out successfully using iodine in acetonitrile to give the thiazolidin-2-thione 13a. To obtain the desired acetamidomethyl derivative 19a, 5-(iodomethyl)-1,3-thiazolidine-2-thione 13a was reacted with sodium azide in DMF to give the azide 14a, which proved very unstable to handle; in addition, variable amounts of elimination products 15a and 16a were formed. Therefore, the iodide displacement was attempted with other nitrogen nucleophiles such as benzylamine, benzhydrylamine, phthalimide etc. However, either unreacted starting material 13a was recovered or only elimination products 15a and/or 16a were obtained. Attempts to convert the azide group of 14a into an amine (with H 2 , Pd/C, PPh 3 /H 2 O; P(OEt) 3 /H 2 O, NaBH 4 ) or into an acetamide group (with CH 3 COSH) failed. Treating azide 14a with propane-1,3-dithiol and triethylamine 13 furnished a very low yield of amine 17a, which was acetylated with acetic anhydride forming the 5-(acetamidomethyl)thiazolidinethione 18a in about 7% overall yield of three steps. The final conversion of thiazolidine-2-thione 18a into thiazolidine-2-one 19a was achieved using propylene oxide and trifluoroacetic acid.
14 This synthetic strategy was applied to the synthesis of Linezolid analogs 3 and 4 as racemates. The reaction sequence used for the conversion of aniline (9a) into 13a transformed 3-fluoro-4-(morpholin-4-yl)aniline (9b) 15 into the 5-(iodomethyl)-1,3-thiazolidine-2-thione 13b, with the iodo-cyclothiocarbamation reaction as last step (Scheme 4). Subsequently, reaction of 13b with lithium azide at room temperature furnished azide 14b as minor product, while the major products were the elimination products 15b and 16b. Following the protocol used for the preparation of 18a, azide 14b was transformed into 5-(acetamidomethyl)thiazolidine-2-thione (RS)-3 in 11% overall yield over the last three steps. Finally, thiazolidine-2-thione (RS)-3 upon reaction with propylene oxide was converted into thiazolidin-2-one (RS)-4 in 63% yield. Due to the inherent basicity of nitrogen nucleophiles the reaction with the iodomethyl intermediates 13a,b provided mainly elimination products 15a,b and 16a,b. The reaction of 13b with the more nucleophilic potassium thioacetate efficiently furnished thioacetate 20 (Scheme 5). Thiazolidinethione 20 was coverted into thiazolidinone 21 upon reaction with propylene oxide. 
Scheme 5
The thioacetate analog 23 of Linezolid 2 was synthesized from mesylate 22 15 and potassium thioacetate (Scheme 6). 17 and M 38 (P) 18 ].
The activity profiles of the thiazolidines (RS)-3, (RS)-4, 13-20 and oxazole 23 against the bacterial strains tested were found to be inferior compared to the oxazolidinones 1 and 2. We observed that there is almost complete loss of antibacterial activity of the thio compounds when compared to the oxygen analogs. Compounds which were inactive in primary screening showed MIC of >16 µg/mL against the bacteria tested. However, the activity profile against the fungi used for screening was found to be a little encouraging. The thiazolidinones (RS)-3 and 19a showed mild antifungal activity (Table 1) . 
Summary
We have shown that the cyclothiocarbamation reaction can be used to synthesize thiazolidinones. Contrary to our expectations, the thiazolidinone analogues were found to be inactive as antibacterials. The present study adds to the importance of the oxazolidinone as the pharmacophore as changes in the ring renders the compounds inactive. Given the precedence that thiazolidinone compounds have hitherto been tested for antifungal activity, 9 future modifications of compounds 3 and 19a may lead to a new generation of inhibitors.
Experimental Section
General Procedures. All reagents were obtained from commercial sources. Solvents were either commercially obtained as analytical grade or freshly distilled prior to use. According to literature protocols 15 IR spectra were recorded on a Paragon 1000pc FT-IR spectrophotometer. LCMS spectra were obtained from a PE-SCIEX AP 1 3000 LC/MS/MS system using electron spray ionization at 80-250 ºC using 6 mM ammonium acetate buffer of pH 6.7.
Triethylammonium phenyldithiocarbamate (10a).
A mixture of aniline 9a (9.31 g, 0.1 mol), carbon disulfide (9.14 g, 0.12 mol) and triethylamine (30.36 g, 0.3 mol) was stirred at room temperature for 16 h. The precipitated salt was filtered off, thoroughly washed with ether and dried in vacuo to furnish the dithiocarbamic acid salt 10a (26.5 g, 98%) as a pale yellow solid. 1 
Benzyl phenyldithiocarbamate (11a).
To the dithiocarbamic acid salt 10a (5.40 g, 20 mmol) in acetonitrile (20 mL) was added benzyl bromide (3.76 g, 22 mmol), and the mixture was stirred at room temperature overnight. The solvent was evaporated under reduced pressure, the residue was diluted with ethyl acetate (50 mL) and washed with water (20 mL). The organic layer was separated, washed with brine and dried (Na 2 SO 4 ). Evaporation of the solvent followed by purification of the residue over a silica gel column using ethyl acetate/hexane (20:80) as eluent Benzyl N-allyl-N-phenyldithiocarbamate (12a). To a solution of the dithiocarbamate 11a (3 g, 11.6 mmol) in dry tetrahydrofuran (50 mL), cooled to 0 °C, was added sodium hydride (50% dispersion in oil, 668 mg, 13.9 mmol), and the mixture was stirred for 30 min. Then, allyl bromide (1.68 g, 13.9 mmol) and tetrabutylammonium iodide (428 mg, 1.16 mmol) were added, and the reaction mixture was gradually warmed to room temperature and stirred overnight. The reaction mixture was concentrated to one-third of its volume, diluted with ethyl acetate (50 mL) and washed with water. The aqueous layer was extracted with ethyl acetate (2 × 10 mL) and the combined organic extracts were washed with brine and dried (Na 2 SO 4 ). 
(5RS)-5-(Iodomethyl)-3-phenyl-1,3-thiazolidine-2-thione (13a).
To a solution of the allyl compound 12a (1.5 g, 5 mmol) in acetonitrile (20 mL) was added iodine (2.53 g, 10 mmol), and the reaction mixture was stirred at room temperature for 2 days. The reaction mixture was diluted with chloroform (50 mL) and washed with saturated aqueous sodium bicarbonate solution (10 mL) followed by sodium thiosulphate (10 mL) solution. The organic layer was further washed with brine and dried (Na 2 SO 4 ). Evaporation of the solvent followed by purification of the residue over a silica gel column using ethyl acetate/hexane (20:80) as eluent furnished the thiazolidine-thiazolidine- 
(5RS)-5-(Azidomethyl)-3-phenyl-1,3-thiazolidine-2-thione (14a).
To a solution of the iodomethyl compound 13a (500 mg, 1.5 mmol) in dimethylformamide (2.5 mL) was added sodium azide (390 mg, 6 mmol), and the reaction mixture was heated at 80 ºC for 3 h. After cooling ethyl acetate (25 mL) was added; the solution was washed with water and brine, and dried (Na 2 SO 4 ). Evaporation of the solvent furnished the crude azide 14a as dark oil (430 mg) which contained also the thiazoles 15a and 16a. (Due to its instability the azide 14a was used as such and the thiazoles 15a and 16a were obtained upon column chromatography after the acetylation step, vide infra (5RS)-5-(Azidomethyl)-3-(3-fluoro-4-morpholin-4-ylphenyl)-1,3-thiazolidine-2-thione (14b).
5-Methyl-3-phenyl-1,3-thiazole-2(3H)-thione (16a
N-[[(5RS)-
As described for 14a, the reaction of 13b (500 mg, 1.14 mmol) dissolved in dimethylformamide (5 mL) with lithium azide (100 mg, 2.24 mmol) dissolved in water (0. 
